Evidence map›Paper›PMID 37311508›Full record

ArticleAnnals of vascular surgery2023

Selective Publication within Vascular Surgery: Characteristics of Discontinued and Unpublished Randomized Clinical Trials.

Mary A Binko, Katherine M Reitz, Rabih A Chaer, Lindsey M Haga, Catherine Go, Fanny S Alie-Cusson, Edith Tzeng, Mohammad H Eslami, Natalie D Sridharan

Abstract read
In one paragraph

Article in Annals of vascular surgery, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Time to publication for results of clinical trials.The Cochrane database of systematic reviews · 2024
    Pooled it
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mary A BinkoSchool of Medicine, University of Pittsburgh, Pittsburgh, PA.
Katherine M ReitzDivision of Vascular Surgery, Department of Surgery, UPMC, Pittsburgh, PA.
Rabih A ChaerDivision of Vascular Surgery, Department of Surgery, UPMC, Pittsburgh, PA.
Lindsey M HagaDivision of Vascular Surgery, Department of Surgery, UPMC, Pittsburgh, PA.
Catherine GoDivision of Vascular Surgery, Department of Surgery, UPMC, Pittsburgh, PA.
Fanny S Alie-CussonDivision of Vascular Surgery, Department of Surgery, UPMC, Pittsburgh, PA.
Edith TzengDivision of Vascular Surgery, Department of Surgery, UPMC, Pittsburgh, PA.
Mohammad H EslamiDivision of Vascular Surgery, Department of Surgery, UPMC, Pittsburgh, PA.
Natalie D SridharanDivision of Vascular Surgery, Department of Surgery, UPMC, Pittsburgh, PA. Electronic address: domenickna2@upmc.edu.

Funding

Vascular Surgery Research Training (VascTrain) ProgramT32HL098036 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Edith Tzeng · 2010 to 2026
$7.2M
NHLBI NIH HHS T32 HL098036NIA NIH HHS L30 AG064730
6 · The paper itself

Abstract

backgroundDiscontinued and unpublished randomized clinical trials (RCTs) are common resulting in biased publication and loss of potential knowledge. The magnitude of selective publication within vascular surgery remains unknown.

methodsRCT relevant to vascular surgery registered (01/01/2010-10/31/2019) on ClinicalTrials.gov were included. Trials ending normally with conclusion of participant treatment and examination were considered completed whereas discontinued trials stopped early. Publications were identified through automatically indexed PubMed citations on ClinicalTrials.gov or manually identified on PubMed or Google Scholar >30 months after the completion date, the date the final participant was examined, allowing time for publication.

resultsOf 108 RCT (n = 37, 837), 22.2% (24/108) were discontinued, including 16.7% (4/24) stopped prior to and 83.3% (20/24) after starting enrollment. Only 28.4% of estimated enrollment was achieved for all discontinued RCT. Nineteen (79.2%) investigators provided a reason for discontinuation, which most commonly included poor enrollment (45.8%), inadequate supplies or funding (12.5%), and trial design concerns (8.3%). Of the 20 trials terminated following enrollment, 20.0% (4/20) were published in peer-reviewed journals and 80.0% (16/20) failed to reach publication. Of the 77.8% trials completed, 75.0% (63/84) were published and 25.0% (21/84) remain unpublished. In a multivariate regression of completed trials, industry funding was significantly associated with decreased likelihood of peer-reviewed publication (OR = 0.18, (95% CI 0.05-0.71), P = 0.01). Of the discontinued and completed trials remaining unpublished, 62.5% and 61.9% failed to report results on ClinicalTrials.gov, respectively, encompassing a total of 4,788 enrollees without publicly available results.

conclusionsNearly 25% of registered vascular RCT were discontinued. Of completed RCT, 25% remain unpublished with industry funding associated with decreased likelihood of publication. This study identifies opportunities to report all findings for completed and discontinued vascular surgery RCT, whether industry sponsored, or investigator initiated.

Indexed as

PublishingSpecialties, SurgicalHumansRandomized Controlled Trials as TopicTreatment OutcomeVascular Surgical Procedures

Identifiers

PMID37311508
PMCPMC13175501

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.